Probing the Meaning of Persistent Propeptide Release in Type 1 Diabetes-Reference-Cited by-同舟云学术

Probing the Meaning of Persistent Propeptide Release in Type 1 Diabetes

Published:2019-01-11 Issue:2 Volume:42 Page:183-185
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Kahn Steven E.¹²^ORCID,Templin Andrew T.¹²^ORCID,Hull Rebecca L.¹²^ORCID,Verchere C. Bruce³

Affiliation:

1. Veterans Affairs Puget Sound Health Care System, Seattle, WA

2. Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, WA

3. Department of Surgery and Department of Pathology and Laboratory Medicine, BC Children's Hospital Research Institute and University of British Columbia, Vancouver, British Columbia, Canada

Funder

U.S. Department of Veterans Affairs

National Institute of Diabetes and Digestive and Kidney Diseases

Canadian Institutes of Health Research

JDRF

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/42/2/183/527227/dci180054.pdf

Reference28 articles.

1. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual β-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT);The DCCT Research Group;J Clin Endocrinol Metab,1987

2. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus;Shah;N Engl J Med,1989

3. Abnormal proinsulin/C-peptide ratio in juvenile diabetes;Ludvigsson;Acta Diabetol Lat,1982

4. Proinsulin immunoreactivity in recent-onset IDDM: the significance of insulin antibodies and insulin autoantibodies;Snorgaard;Diabetes Care,1996

5. Proinsulin secretion is a persistent feature of type 1 diabetes;Sims;Diabetes Care,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The processing intermediate of human amylin, pro-amylin(1–48), has in vivo and in vitro bioactivity;Biophysical Chemistry;2024-05

2. Islet amyloid toxicity: From genesis to counteracting mechanisms;Journal of Cellular Physiology;2021-10-12

3. The β Cell in Diabetes: Integrating Biomarkers With Functional Measures;Endocrine Reviews;2021-06-28

4. Altered β-Cell Prohormone Processing and Secretion in Type 1 Diabetes;Diabetes;2021-05

5. Analysis of Proline Substitutions Reveals the Plasticity and Sequence Sensitivity of Human IAPP Amyloidogenicity and Toxicity;Biochemistry;2020-01-10